Related Experiment Video
Updated: Aug 6, 2026

06:37
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
Published on: October 20, 2010
Fusion lymphoscintigraphy with a 24-hour Tc-99m MDP bone scan for sentinel lymph node detection and imaging
1Department of Nuclear Medicine, William Beaumont Hospital, Royal Oak, Michigan 48073-6769, USA.
Clinical Nuclear Medicine
|January 4, 2001
Summary
A whole-body bone scan before lymphoscintigraphy improves sentinel lymph node identification in breast cancer patients. This combined imaging approach offers greater anatomical precision for surgeons.
Area of Science:
- Nuclear Medicine
- Oncology
- Surgical Imaging
Background:
- Sentinel lymph node biopsy is crucial for breast cancer staging.
- Accurate identification of sentinel nodes is essential to prevent unnecessary axillary dissection.
- Current lymphoscintigraphy methods can be enhanced for better anatomical localization.
Observation:
- A whole-body technetium-99m methylene diphosphonate (Tc-99m MDP) bone scan was performed on a patient with breast carcinoma.
- Subsequently, lymphoscintigraphy using filtered Tc-99m sulfur colloid was conducted for sentinel node detection.
- The bone scan images provided a clear anatomical reference for the lymphoscintigraphic findings.
Findings:
- The combined bone scan and lymphoscintigraphy demonstrated clear delineation of right axillary lymph nodes relative to the rib cage.
- Performing the bone scan immediately prior to lymphoscintigraphy facilitated precise sentinel lymph node identification.
- This integrated imaging technique proved more anatomically precise than traditional flood source methods.
Implications:
- This combined imaging strategy can enhance surgical precision in sentinel lymph node biopsy for breast cancer.
- Consideration of a Tc-99m MDP bone scan preceding lymphoscintigraphy is recommended for patients requiring both imaging modalities.
- This approach may improve staging accuracy and guide treatment decisions in breast carcinoma management.

